Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 trials
PTI, Mar 3, 2021, 7:25 PM IST
New Delhi: Vaccine major Bharat Biotech on Wednesday said its COVID-19 vaccine, Covaxin, has demonstrated an interim vaccine efficacy of 81 per cent in Phase 3 clinical trials.
The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.
”Today is an important milestone in vaccine discovery, for science and our fight against coronavirus. With today’s results from our Phase 3 clinical trials, we have now reported data on our COVID-19 vaccine from Phase 1, 2, and 3 trials involving around 27,000 participants,” Bharat Biotech Chairman and Managing Director Krishna Ella said.
Covaxin demonstrates a high clinical efficacy trend against COVID-19 but also significant immunogenicity against the rapidly emerging variants, he added.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Covaxin and Oxford-AstraZeneca’s Covishield are the two vaccines that are being administered in the country.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
UP: Head constable held for killing government teacher, govt announces Rs 25 lakh ex gratia to kin
KPCC urges poll panel to reschedule election date in Kerala
ED a political weapon, SC dismissed its claim that AAP got Rs 100-cr in kickbacks: Atishi
Krishna Janmabhoomi case: SC disposes of plea against HC order on consolidation of 15 suits
Pashupati Paras resigns from Union cabinet, accuses BJP of injustice
MUST WATCH
Latest Additions
UP: Head constable held for killing government teacher, govt announces Rs 25 lakh ex gratia to kin
Gelatin sticks with detonators & other explosives recovered in Bengaluru, case filed
KPCC urges poll panel to reschedule election date in Kerala
BJP holds protest against assault on trader for playing ”Hanuman Chalisa” in Bengaluru
ED a political weapon, SC dismissed its claim that AAP got Rs 100-cr in kickbacks: Atishi